No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MNMD241220C2000
- 6.20
- +1.30+26.53%
15min DelayClose Dec 20 16:00 ET
6.20High4.98Low
4.98Open4.90Pre Close2 Volume2 Open Interest2.00Strike Price1.12KTurnover0.00%IV14.53%PremiumDec 20, 2024Expiry Date5.16Intrinsic Value100Multiplier-1DDays to Expiry1.04Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.52Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Mind Medicine Price Target Announced at $20.00/Share by Chardan Capital
Mind Medicine Initiated at Buy by Chardan Capital
MindMed To Be Added To The Nasdaq Biotechnology Index, Effective At Market Open On December 23, 2024
MindMed to Be Added to the Nasdaq Biotechnology Index
Mind Medicine Analyst Ratings
Oppenheimer Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20